Partners-based HIV Treatment for Sero-concordant Couples attending Antenatal Care
Principal Investigator(s):
Carolyn Audet, Ph.D.
Partnerships for Enhanced Engagement in Research Liberia (PEER/Liberia) Consortium
Principal Investigator(s):
Bonnie Miller, M.D.
Troy Moon, M.D. M.P.H.
Marie Martin, M.Ed., Ph.D.
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis "RePORT-Brazil"
Principal Investigator(s):
Timothy R. Sterling, M.D.
Valeria Cavalcanti Rolla, M.D., Ph.D.
Mobile Health and Treat (mHAT) for Malaria Elimination
Principal Investigator(s):
Martin Were, M.D., M.S.
David Wright, Ph.D.
Management of severe acute malnutrition in children with sickle cell disease greater than 5 years of age living in northern Nigeria
Project Details: NIH Reporter
Abstract Text
Margaret Houston
Margaret
Houston
Lead Administrative Assistant
margaret.houston@vumc.org
PeerNaija: A Mobile Health Platform
The scale-up of global antiretroviral therapy (ART) represents an unparalleled global health success story, leading to impressive overall reductions in HIV-related morbidity and mortality. However, adolescents and young adults (AYA), especially those in Sub-Saharan Africa, have largely been left out of this story. While AIDS-related deaths declined by 30% for adults from 2005-2012, they increased by 50% among AYA over the same period, making AIDS the leading cause of death among African youth. AYA living with HIV perform poorly across the entire care continuum.
New grant supports child neurology and epilepsy researchers in Nigeria
Aminu Kano Teaching Hospital (AKTH) and Bayero University Kano (BUK) in Kano, Nigeria, and Vanderbilt Institute for Global Health (VIGH) have a long history of successful NIH-funded collaborations in childhood brain disorders.
These three institutions are partnering on a new $1.2 million, five-year training program funded by the Fogarty International Center at the National Institutes of Health (NIH) under Fogarty’s Chronic, Non-Communicable Diseases and Disorders Across the Lifespan Training Program.
NIH support bolsters research on persistent microalbuminuria in Nigeria
The Vanderbilt Institute for Global Health (VIGH) and Aminu Kano Teaching Hospital (AKTH) in Kano, Nigeria have received a federal grant to study the factors associated with microalbuminuria among participants in an ongoing clinical trial of genetically at-risk HIV-positive adult Nigerians.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant will provide $2.2 million over the next four years.